SENSEX    73905.88       52.94    |    NIFTY    22390.1       -12.30 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Hot Pursuit
Scrips, which has significant changes during the market hours for last one week.
Aster DM Healthcare to shut clinics in Philippines
14-Dec-19   10:24 Hrs IST

Aster DM Healthcare in an exchange filing after market hours yesterday, 13 December 2019 said that its subsidiary operated three clinics in Philippines.

The management entered into an agreement for asset sale of two of its clinics with Aventus Medical Care INC. on 12 December 2019.

It is estimated to close the operations of all the clinics by 31 December 2019.

The revenue from Philippines-based unit was Rs 5.27 crore, which represents 0.07% of the total revenue of the company. The net loss of the subsidiary is Rs 8.18 crore while the net worth is Rs (17.99) crore.

On technical front, the stock trades above its 50 and 200 days simple moving average placed at 138.32 and 136.56 respectively.

Shares of Aster DM Healthcare closed 0.4% higher at Rs 152.30 on BSE. Aster DM Healthcare has gained 25.3% in last three months as compared to a 0.15% rise in Nifty Pharma index.

On a consolidated basis, the company's net profit fell 71.7% to Rs 3.12 crore on a 13.6% increase in the net sales to Rs 2086.88 crore in Q2 September 2019 over Q2 September 2018.

Aster DM Healthcare is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 88.96 1.07
United Kingdom (GBP) 1.16 1.00 103.28 1.24
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.81 83.31 1.00
Market News << ALL News
  25-Apr-2024, (09:26 )  Kotak Bank tumbles a..
  25-Apr-2024, (09:30 )  Kotak Mahindra Bank ..
  25-Apr-2024, (09:30 )  Macrotech Developers..
  25-Apr-2024, (08:28 )  Rites inks MoU with ..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)